Bio Insight Bio-Interaction
Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...
January 10, 2025 | News
Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
In an exclusive interview with BioPharma APAC, Ed Deng, Co-founder and CEO of Health2Sync, delves into the transformative impact of their collabora...
December 24, 2024 | Interaction
India’s Biotech Boom: Supriya Kashikar on Startups, Innovation, and the Road to 2030
India’s biotechnology sector is on a trajectory to reach $300 billion by 2030, fueled by a dynamic startup ecosystem, robust government initiatives l...
December 17, 2024 | Interview
Driving Precision Medicine with AI: Tomasz Jetka, PhD, on Ardigen’s Vision for 2025
In an exclusive conversation with BioPharma APAC, Tomasz Jetka, PhD, Director of AI at Ardigen, delves into the company's ambitious plans to revolutionize ...
December 16, 2024 | Interview
Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
In an exclusive interview with BioPharma APAC, Mr. Brendan O’Callaghan, Executive Vice President, Manufacturing & Supply at Sanofi, sheds light o...
December 09, 2024 | News
AstraZeneca's Drive to Transform Lung Cancer Care in LMICs
In an exclusive interview with BioPharma APAC, Ti Hwei How, Vice President of International Oncology & Market Access at AstraZeneca, sh...
December 02, 2024 | Interview
Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
In an exclusive conversation with BioPharma APAC, Stefan Scheidl, VP and Global Head of Ophthalmology Medical Affairs at Roche, delves into the g...
December 02, 2024 | Interview
Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
In an exclusive interview with BioPharma APAC, Pam Cheng, Executive Vice President of Global Operations & IT and Chief Sustainability Officer at AstraZ...
November 15, 2024 | Interview
Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...
November 01, 2024 | Interview
Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
As JLABS Singapore marks its first anniversary, Alessandro Falcone, Head of JLABS Singapore, speaks with BioPharma APAC about the incubator’s rapid s...
October 30, 2024 | News
Why Singapore is the World’s New Pharma Powerhouse: Unpacking the Secrets Behind Its Manufacturing Boom
Singapore’s pharmaceutical revolution: How data and digital transformation are fueling a global hub Once primarily recognized for it...
October 22, 2024 | Opinion | By Venkatesh Arunachalam, General Manager of the Life Science Manufacturing group at Cognizant
Sanyou Bio CEO Lang Guojun Introduces World’s Largest Super-Trillion Molecule Library
In an interview with Tongxieyi, Sanyou Bio’s CEO Lang Guojun proudly announced the launch of the world’s largest super-trillion molecule librar...
October 21, 2024 | Interview
Breaking Down Portal Fatigue in Cell and Gene Therapy: Insights from TrakCel’s Experts
In this exclusive BioPharma APAC Q&A, Dr. Matthew Lakelin, Co-Founder and Head of Consultancy Services at TrakCel, and Antonios Spanos, Industry Adviso...
October 17, 2024 | Interview
Overcoming Commercial Hurdles in Biopharma: A Conversation with Sudhir Kandarth, General Manager, Asia Pacific, Veeva Systems
As biopharma companies navigate an increasingly complex commercial landscape, achieving excellence demands more than innovation alone. With shifts ...
October 11, 2024 | Interview
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
